Teva and Allergan reach opioid crisis deal; the Covid-19 vaccine market grows crowded

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Teva and Allergan reach $107 million deal with Rhode Island over opioid crisis By Ed Silverman ERIC BARADAT/AFP via Getty Images The deal calls for the companies to pay $28.5 million in cash. Teva will also provide doses of drugs used to treat overdoses and opioid use disorder. Read More STAT+: When should drugmakers go all in and cut off essential medicines to Russia? By Ed Silverman ALEXANDER NEMENOV/AFP via Getty Images The logic in withholding rests on the premise that such a move would eventually help convince Russia to end the violence in Ukraine. Read More STAT+: What makes a biotech a biotech? By Kate Sheridan Adobe Historically, experts distinguished between biotech and pharma companies based on how a therapeutic was made. But the line’s gotten fuzzy. Read More Sponsor content by STAT Events The STAT Breakthrough Science Summit On March 31, take an inside look at the technologies and procedures set to redefine medicine, and change patient care in the years to come. You'll hear from the CEOs, scientists, entrepreneurs at the forefront of these efforts. Get your pass now, and use your STAT+ subscriber login to unlock a 20% discount. The Covid-19 vaccine market is getting crowded — as demand begins to wane By Helen Branswell JOEL SAGET/AFP via Getty Images The prospects for those still struggling to prove their vaccines are protective are becoming ever slimmer. Read More Monday, March 21, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser